Introduction {#sec1}
============

Functional annotation of protein sequence with high accuracy (AC) has become one of the most important issues in understanding the molecular mechanism of life \[[@ref1], [@ref2]\] and has great biological \[[@ref3]\], pathological \[[@ref6]\] and pharmaceutical \[[@ref9]\] implications. With the rapid accumulation of a wealth of protein sequences, the functional annotation of proteins has become increasingly challenging \[[@ref17]\]. Particularly, only \~1% of all protein sequences in UniProt \[[@ref18]\] have experimentally verified functions \[[@ref19]\], and it is estimated that \~90% of the annotated proteins in the ontology of molecular function (MF)/biological process (BP) \[[@ref23]\] come from only nine species \[[@ref24]\]. Even for these nine model organisms, \~60% of their proteins have not had any experimentally determined MF/BP term \[[@ref24]\]. Traditional methods for protein function annotation are mainly based on the experiments such as mass spectrometry, microscopy and RNA interference, which are reported as very time-consuming and resource-demanding because of the low throughput and restricted scope of methodology \[[@ref25]\]. As such, the computational approaches of significantly accelerated analysis process and enhanced AC are greatly desired \[[@ref32]\].

Computational methods popular in current protein function prediction \[[@ref38]\] can be roughly divided into three categories: information, structure and sequence based \[[@ref41]\]. The information-based methods \[[@ref26], [@ref42]\] are suitable for predicting the functions of interacting proteins \[[@ref46]\] and proteins from coexpressed genes \[[@ref41], [@ref47], [@ref50]\] but seriously restricted by the great noises in protein--protein interaction data and insufficient number of annotated proteins \[[@ref17], [@ref41], [@ref49]\]. The structure-based methods \[[@ref51]\] are found to be accurate \[[@ref47], [@ref55]\] but significantly limited by the lack of crystallized protein folds or structures \[[@ref47]\] and the unclear relations between structural similarity and functional similarity in many cases \[[@ref41], [@ref56]\]. Among those three method categories, the sequence-based ones have now become the most widely applied method in protein function prediction \[[@ref41]\] due to the relatively easy access of abundant high-quality sequence data in public database \[[@ref46], [@ref50]\] and its powerful ability to predict the function of remotely relevant protein and the homologous proteins of distinct functions \[[@ref47], [@ref57]\]. There are two types of sequence-based approaches: similarity based and *de novo* \[[@ref41]\]. Particularly, similarity-based methods (like BLAST (a tool used for finding regions of similarity between biological sequences) \[[@ref58]\] and HMMER (a tool used for searching sequence databases for sequence homologs, and for making sequence alignments) \[[@ref59]\]) assign an unannotated protein with the function of another protein similar in sequence to that protein \[[@ref41]\]. Since the similarity-based methods are reported to depend heavily on the sequence homology, the *de novo* ones are considered as an effective complement \[[@ref41], [@ref60]\], which is irrespective of sequence similarity and good at predicting the distantly related proteins and the homologous proteins of distinct functions \[[@ref61], [@ref62]\]. The *de novo* methods are generally based on supervised learning model, such as *K*-nearest neighbor (KNN) \[[@ref63]\], probabilistic neural network (PNN) \[[@ref64]\] and support vector machine (SVM) \[[@ref62]\]. They are reported to be powerful in predicting the functions of proteins \[[@ref65]\] and other molecules \[[@ref71]\].

However, the high false discovery rate of the sequence-based protein function prediction remains a severe problem \[[@ref72]\]. In particular, the databases adopted by similarity-based methods for searching homology often contain noise, and the relation between sequence similarity and homology is sometimes unclear \[[@ref41]\]; the representativeness of the training data analyzed by *de novo* method is not always sufficient \[[@ref62]\]. In the past few years, several pioneer efforts have been made to solve the problems \[[@ref77]\]. On one hand, a stringent score cutoff is adopted by BLAST and HMMER to control the false discovery hits in detecting homologies \[[@ref78]\]. On the other hand, some machine learning methods have been used to identify false homologies \[[@ref79], [@ref80]\], and a putative negative training data set derived from representative seed proteins of Pfam families, which has high coverage of the protein family space, is constructed to reduce the false discovery rate \[[@ref62]\]. Recently, the deep learning algorithm is frequently applied in sequence and omics data analysis \[[@ref81], [@ref82]\], biomedical imaging and biomedical signal processing \[[@ref83], [@ref84]\], which demonstrates a remarkable performance \[[@ref85]\]. In protein function annotation, a multitask deep neural network has been designed to predict the function of the proteins from multiclasses \[[@ref83]\], and a deep restricted Boltzmann machine is used to annotate the proteins with Gene Ontology (GO) term in the deep position of a directed acyclic graph \[[@ref23], [@ref86]\]. Moreover, a multiclassification model has been constructed to predict protein functional classes \[[@ref87]\]. Although those methods are reported to be effective in elevating protein annotation AC \[[@ref88]\], their ability in controlling false annotation rates is either limited or not systematically evaluated \[[@ref57]\]. Thus, the significant enhancement on controlling false discovery rate is still urgently needed, and the corresponding tool is required in the filed of protein function annotation \[[@ref62]\].

In this study, a protein encoding strategy, together with a deep learning algorithm, was proposed to control the false discovery rate in protein function annotation, and its performances were systematically compared to that of the traditional similarity-based and *de novo* methods. First, the training and testing data sets with the highest and lowest similarities were separately constructed for distinguishing the performances among different methods. Second, a protein encoding strategy was proposed and integrated to deep learning-based algorithm, and its performances were compared with other traditional methods from multiple perspectives. Third, the capacity of the proposed method in controlling the false discovery rate was assessed by the comprehensive genome scanning and enrichment factor (EF). In summary, this study provided a comprehensive analysis on the performances of a newly proposed protein function annotation strategy.

Materials and methods {#sec2}
=====================

The functional families studied in and protein sequences collected for this analysis {#sec3}
------------------------------------------------------------------------------------

In total, 20 protein families of different GO terms were collected from diverse subclasses in the MF of the GO database by maximizing their representativeness among all MF categories \[[@ref23]\], and the GO families with different numbers of proteins were selected to enable the discussion of the effect of sample size on prediction result. The total numbers of proteins in these GO families were from \~800 to \~33 500 (after removing repeated protein sequences). As provided in [Table 1](#TB1){ref-type="table"}, each studied GO family was indicated by a GO ID \[[@ref23]\], and the total number of proteins (with sequence length of ≤1000) in the 20 GO families were listed (ranging from 802 to 33 178). The sequences of the proteins in these 20 families were collected from the UniProt database \[[@ref89]\], and the repeated sequences were removed to avoid possible bias.

###### 

Twenty GO families collected from diverse subclasses in MF of GO database by maximizing their representativeness among all MF categories. The numbers of proteins (with the sequence length of ≤1000) in these GO families were from 802 to 33 178, and the number of *Pfam* families covered by each GO family was from 57 to 1092. These GO families were sorted by their total numbers of proteins included

  Functional GO families studied in this work          GO ID        No. of proteins   No. of *Pfam* families covered   No. of proteins in training data set   No. of proteins in testing data set
  ---------------------------------------------------- ------------ ----------------- -------------------------------- -------------------------------------- -------------------------------------
  Cyclase activity                                     GO:0009975   802               57                               624                                    178
  Cyclin-dependent protein kinase activity             GO:0097472   2951              64                               2295                                   656
  Phosphoprotein phosphatase activity                  GO:0004721   4324              152                              3363                                   961
  Transcription coregulator activity                   GO:0003712   4684              346                              3643                                   1041
  Positive regulation of transferase activity          GO:0051347   4732              355                              3680                                   1052
  Negative regulation of catalytic activity            GO:0043086   6239              512                              4853                                   1386
  Transferase activity, transferring acyl groups       GO:0016746   8845              238                              6879                                   1966
  Ubiquitin-like protein transferase activity          GO:0019787   9553              255                              7430                                   2123
  Transferase activity, transferring glycosyl groups   GO:0016757   9694              278                              7540                                   2154
  Structural constituent of ribosome                   GO:0003735   10 492            204                              8160                                   2332
  Regulation of hydrolase activity                     GO:0051336   10 995            686                              8551                                   2444
  Positive regulation of catalytic activity            GO:0043085   11 803            719                              9180                                   2623
  Positive regulation of MF                            GO:0044093   13 677            884                              10 637                                 3040
  Peptidase activity                                   GO:0008233   18 665            597                              14 517                                 4148
  DNA-binding transcription factor activity            GO:0003700   19 677            693                              15 304                                 4373
  Hydrolase activity, acting on ester bonds            GO:0016788   22 599            802                              17 578                                 5021
  Protein kinase activity                              GO:0004672   23 068            642                              17 942                                 5126
  Hydrolase activity, acting on acid anhydrides        GO:0016817   28 327            779                              22 032                                 6295
  Signaling receptor activity                          GO:0038023   28 700            525                              22 322                                 6378
  Catalytic complex                                    GO:1902494   33 178            1092                             25 805                                 7373

Constructing the data sets of training and testing {#sec4}
--------------------------------------------------

Since a binary classification model was constructed for the studied GO families, the proteins in each family were considered as positive data. In order to significantly enhance the representativeness of negative data (nonmembers of a GO family), a putative data set was therefore constructed by considering the following steps: (1) the *Pfam* family of each protein in a particular GO family was collected from the *Pfam* database \[[@ref90]\], (2) the *Pfam* families of all proteins in that GO family were considered as the 'positive *Pfam* family' and (3) three representative seed proteins from the rest of the *Pfam* families (named as 'negative *Pfam* family') were collected to construct a putative negative data set (PND). Since the resulting PND was characterized by its proteins of significantly diverse *Pfam* families, its representativeness on those nonmembers of a GO family was substantially enhanced and could be applied for controlling false discovery \[[@ref57], [@ref62]\].

Moreover, the level of representativeness of the studied data sets has great impacts on the performances of the analyzed methods \[[@ref62]\]. Particularly, the higher similarity between the data set used to construct models and that to test models could result in better functional prediction \[[@ref57]\]. Thus, the training and testing data sets with the highest or the lowest similarity were constructed for the analyses here. First, the sequences were converted to digital vectors using the novel strategy proposed in this study (described in the following section). Second, the positive data set (containing all proteins from a particular GO family) was classified into six groups using the *K*-means clustering algorithm (the distance used in this clustering was Euclidean distance) \[[@ref91]\]. On one hand, in order to construct the training and testing data sets with the highest similarity, one-third of proteins in each group of the positive data set were randomly selected out to construct the testing data set (combining six groups), and the remaining two-thirds were used to form training data set (combining six groups). On the other hand, to construct the training and testing data sets with the lowest similarity, two groups were randomly selected out from those six groups to construct the testing data set, and the remaining four were used to form training data set. For both situations, two out of those three representative seed proteins from the negative *Pfam* families were randomly selected out to form the training data set, and the remaining one was used to construct the testing data set. Furthermore, to evaluate the false discovery rate of those studied methods, all protein sequences in the human genome were collected from the UniProt database \[[@ref89]\].

The methods studied and assessed in this work {#sec5}
---------------------------------------------

The sequence homology was the basis of protein function prediction, which could be detected by similarity analysis among sequences. Generally, the sequences with higher similarity were more likely homologous. BLAST was one of the most popular tools for sequence similarity analysis \[[@ref58]\]. Herein, the sequences of proteins in the training data set of each GO family were collected to construct a searchable database, and then any query protein was searched against this database using BLAST and annotated with the function of the most similar protein. HMMER was another popular tool for sequence similarity analysis used in this study, which was based on the hidden Markov model \[[@ref59]\]. Similar to the BLAST, the searchable database was also constructed based on the sequences of proteins in the training data set of each GO family. Then, any protein was searched against this database using HMMER \[[@ref59]\] and annotated based on the most similar one.

Moreover, there were three *de novo* methods studied and assessed in this study. The SVM tried to find a hyperplane to separate the members from nonmembers of a particular GO family by maximizing the margin defined in protein feature space \[[@ref92]\]. The KNN predicted the class of a protein by the majority vote of its neighbors with a given distance metric \[[@ref93]\], and the PNN was a neural network based on Bayesian decision theory \[[@ref94]\]. These three methods were directly applied under the Python environment. As reported in the previous studies \[[@ref57], [@ref62]\], a method for converting the protein sequence to the digital feature vector had been successfully applied in SVM, KNN and PNN and had been shown good performance in protein function prediction. This method converted the protein sequence into the digital vector according to its properties and composition of amino acids \[[@ref62], [@ref95]\]. The properties adopted here included (1) hydrophobicity, (2) Van der Waals volume, (3) polarity, (4) polarizability, (5) charge, (6) secondary structure, (7) solvent accessibility and (8) surface tension \[[@ref62], [@ref96]\]. Each property was represented by three groups of descriptors: the global composition of given amino acid, frequencies with which the property changes along entire protein and distribution pattern of property along sequence. The detail on this digitalizing method could be found in previous studies \[[@ref57], [@ref62]\].

![The workflow of the deep learning algorithm (CNN) applied together with the sequence encoding technique proposed in this study.](bbz081f1){#f1}

The deep learning algorithm used in this study was the convolutional neural network (CNN). As shown in [Figure 1](#f1){ref-type="fig"} (Encoding Layer), a new sequence encoding technique was first proposed to generate a 1000 × 5 binary array for any protein sequence. Particularly, each amino acid was encoded by a 5-bit binary number (from \[0,0,0,0,1\] for alanine to \[1,0,1,0,0\] for tyrosine). Only the proteins with the sequence length of no more than 1000 amino acids were analyzed in this study, which constitute the majority (\>98%) of the proteins in any GO family. For the proteins of sequence length of less than 1000 amino acids, their empty amino acid positions were complemented by the 5-bit binary number \[0,0,0,0,0\]. Moreover, for the amino acids that were not among those 20 common ones, they were encoded by another number \[1,0,1,0,1\]. Second, CNN was applied, which consisted of multiple layers: a convolutional layer, a pooling layer, two fully connected layers and a softmax layer ([Figure 1](#f1){ref-type="fig"}). The encoding array connected directly with the convolutional layer, which scanned the encoding array through an *m~k~* × 5 convolution kernel and resulted in a feature vector: $$\documentclass[12pt]{minimal}
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The CNN model was implemented with the Python programming language and the TensorFlow library. The binary cross-entropy loss function was adopted in all models training, and the Adam \[[@ref101]\] optimizer (learning rate = 0.001, *β*~1~ = 0.9, *β*~2~ = 0.999 and *ε* = 10^−8^) was used for the optimization during back-propagation. The weight parameters were initialized with the He initialization method \[[@ref102]\], and biases were initialized to zero. The batch normalization was applied in the fully connected layers before ELU activation function for accelerating the speed of convergence, and the strategy of dropout \[[@ref103]\] was also used in the fully connected layer with a drop rate of 0.6 to randomly remove a certain number of neurons at each training step in order to prevent the overfitting of the neural network.

###### 

The performances of three *de novo* (SVM, KNN and PNN) and the deep learning (CNN) methods proposed in this study on the training and testing data sets (for eight representative GO families) with the highest similarity based on popular measurements (SE, SP, PR, AC and MCC). Each GO family was denoted by its GO ID, and its corresponding GO term was shown in [Table 1](#TB1){ref-type="table"}

  GO ID        CNN    SVM    KNN    PNN                                                                                                             
  ------------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------
  GO:0097472   85.2   99.9   99.1   98.5   0.91   81.0   99.1   90.2   97.3   0.84   70.9   97.7   76.4   95.1   0.71   72.7   98.6   84.7   96.2   0.76
  GO:0004721   79.5   99.2   93.9   96.6   0.85   65.2   99.3   93.2   94.7   0.75   68.0   95.6   70.8   91.9   0.65   55.5   98.7   87.0   92.9   0.66
  GO:0051347   81.3   99.6   97.5   96.9   0.87   78.4   97.3   83.4   94.5   0.78   75.6   93.5   66.9   90.9   0.66   63.8   99.1   92.8   93.9   0.74
  GO:0003735   80.7   98.7   95.8   93.8   0.84   87.2   97.6   93.2   94.8   0.87   84.7   95.6   87.8   92.6   0.81   84.9   95.5   87.7   92.6   0.81
  GO:0016746   71.7   96.2   85.8   90.2   0.72   70.5   96.6   86.8   90.2   0.72   70.7   92.5   75.2   87.2   0.65   64.8   93.7   76.8   86.7   0.62
  GO:0043085   69.3   98.1   94.3   89.2   0.74   75.4   95.2   87.5   89.1   0.74   78.8   87.1   73.2   84.5   0.65   66.7   95.6   87.2   86.7   0.68
  GO:0003700   81.1   95.0   92.3   89.0   0.78   82.8   94.8   92.2   89.7   0.79   81.9   90.9   87.0   87.1   0.74   84.3   89.0   85.0   87.0   0.73
  GO:0044093   80.7   93.5   86.6   89.1   0.76   78.7   94.1   87.5   88.8   0.75   80.6   85.5   74.5   83.8   0.65   72.6   92.5   83.7   85.6   0.68

Assessing the AC and false discovery rate of protein function annotation {#sec6}
------------------------------------------------------------------------

Five popular measurements, such as sensitivity (SE), specificity (SP), precision (PR), AC and Matthews correlation coefficient (MCC) \[[@ref57], [@ref104]\], were adopted in this study to evaluate the performance of each protein functional annotation method. Since the SP was reported to be effective in evaluating the methods' false discovery rate \[[@ref57]\], it was adopted in this study to assess the false discovery rate of the *de novo* methods and the constructed deep learning model based on the testing data set. Moreover, in order to further assess the false discovery rate of methods, a real-world application of the human genome scanning was performed with each method. For BLAST and HMMER, the training data set was used to construct the searching databases. For *de novo* and deep learning methods, the training data set was applied to train the models. Because it is not necessary to use the negative data set in predictions with BLAST and HMMER, the SP cannot be calculated in the genome scanning for both methods, the false discovery rate was evaluated by the EF for discovering the proteins in each GO family: $$\documentclass[12pt]{minimal}
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}{}$N$\end{document}$ denoted the total number of proteins in the studied genome and $\documentclass[12pt]{minimal}
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}{}${N}_{\mathrm{T}}$\end{document}$ referred to the total number of proteins in the testing data set truly belonging to the studied GO family. The value of EF is no less than zero; however, only when the EF value is larger than 1, there is an enrichment. The larger the EF, the lower the false discovery rate.

###### 

The performances of three *de novo* (SVM, KNN and PNN) and the deep learning (CNN) methods proposed in this study on the training and testing data sets (for 20 studied GO families) with the lowest similarity based on popular measurements (SE, SP, PR, AC and MCC). Each GO family was indicated by its GO ID, and its corresponding GO term was provided in [Table 1](#TB1){ref-type="table"}

  GO ID        CNN    SVM    KNN    PNN                                                                                                             
  ------------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------
  GO:0009975   26.4   99.9   94.0   97.9   0.49   11.8   99.8   67.7   97.4   0.28   10.1   98.3   14.4   95.8   0.10   16.3   96.3   11.2   94.1   0.10
  GO:0097472   67.7   99.9   99.6   96.9   0.81   39.0   99.3   85.1   93.5   0.55   43.3   97.8   67.6   92.6   0.50   40.2   98.6   74.8   93.0   0.52
  GO:0004721   55.6   99.5   94.5   93.6   0.70   28.4   99.2   84.0   89.7   0.45   36.4   95.2   54.2   87.3   0.38   32.4   97.3   64.8   88.5   0.40
  GO:0003712   32.7   99.7   94.2   89.9   0.52   20.4   98.5   70.2   87.1   0.33   35.9   94.5   52.5   85.9   0.36   38.1   92.9   47.8   84.9   0.34
  GO:0051347   42.5   99.9   98.7   91.4   0.62   26.9   98.8   79.3   88.2   0.42   37.4   92.7   47.0   84.5   0.33   37.5   96.0   62.0   87.4   0.42
  GO:0043086   35.5   99.1   90.4   87.1   0.52   17.4   98.0   66.4   82.8   0.28   28.7   91.8   44.8   79.9   0.25   10.1   99.9   96.6   83.0   0.28
  GO:0016746   40.0   97.7   84.9   83.7   0.51   27.1   93.7   58.0   77.5   0.28   30.0   86.2   41.1   72.5   0.18   9.9    99.4   84.8   77.7   0.24
  GO:0019787   79.9   96.2   87.8   92.0   0.79   37.7   96.1   76.9   81.1   0.44   34.8   90.3   55.4   76.0   0.30   40.1   89.9   57.9   77.1   0.34
  GO:0016757   48.9   97.3   86.5   84.7   0.57   22.0   96.2   68.0   77.0   0.29   38.5   84.9   47.2   72.8   0.25   32.7   92.7   61.2   77.1   0.32
  GO:0003735   87.6   97.3   92.4   94.6   0.86   87.9   96.6   90.8   94.2   0.85   86.0   95.0   86.7   92.6   0.81   84.4   93.1   82.2   90.7   0.77
  GO:0051336   28.3   98.9   91.2   78.2   0.43   23.0   94.4   63.1   73.5   0.26   38.6   84.3   50.5   70.9   0.25   46.5   83.2   53.4   72.4   0.31
  GO:0043085   44.0   98.0   90.7   81.3   0.54   32.9   94.9   74.3   75.7   0.37   54.8   79.8   54.9   72.1   0.35   57.8   80.5   57.0   73.5   0.38
  GO:0044093   41.6   96.3   85.4   77.5   0.48   29.0   94.6   73.9   72.0   0.33   46.7   80.2   55.4   68.7   0.28   23.1   97.3   81.7   71.7   0.33
  GO:0008233   62.0   92.9   86.0   80.2   0.59   49.2   92.8   82.7   74.9   0.48   67.9   72.6   63.4   70.7   0.40   60.6   80.7   68.7   72.4   0.42
  GO:0003700   77.7   94.1   90.7   87.1   0.74   62.2   89.1   81.0   77.6   0.54   67.0   85.2   77.1   77.4   0.53   68.2   84.5   76.6   77.5   0.54
  GO:0016788   53.9   89.1   81.0   72.8   0.46   45.9   86.5   74.5   67.6   0.36   64.8   65.0   61.5   64.9   0.30   55.9   78.2   68.9   67.8   0.35
  GO:0004672   76.8   95.5   93.7   86.8   0.74   49.1   88.0   78.1   69.9   0.41   60.3   71.7   65.0   66.4   0.32   50.9   86.6   76.8   70.0   0.40
  GO:0016817   60.7   95.0   92.9   77.1   0.59   45.3   84.9   76.5   64.3   0.33   68.2   60.8   65.4   64.7   0.29   67.1   65.4   67.8   66.3   0.32
  GO:0038023   71.3   91.6   90.0   81.1   0.64   59.4   90.6   87.1   74.5   0.52   57.2   83.7   78.9   70.0   0.42   57.0   84.7   79.9   70.4   0.43
  GO:1902494   49.6   87.2   83.4   66.0   0.39   42.8   79.9   73.4   59.0   0.24   58.6   62.5   66.9   60.3   0.21   58.9   66.6   69.6   62.3   0.25

![Variations (the actual value of each method subtracted by the minimum value among four different methods) of four measurements among different protein function annotation methods: (**A**) MCC, (**B**) AC, (**C**) SE, (**D**) SP. On the right side, the statistical differences between any two methods were provided as the violin box plots. ^\*^ indicated great difference of *P* \< 0.05, and ^\*\*^ denoted significant difference of *P* \< 0.01. Detailed *P*-values are provided in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}.](bbz081f2){#f2}

Results and discussion {#sec7}
======================

Methods' performances based on the training and testing data sets with the highest similarity {#sec8}
---------------------------------------------------------------------------------------------

The performances of studied methods were first calculated and assessed based on the constructed training and testing data sets with the highest similarity (the way to construct such data sets was provided in the second section of Materials and Methods). As shown in [Table 2](#TB2){ref-type="table"}, eight representative GO families were selected randomly from all 20 studied GO families, and the performances of three *de novo* (SVM, KNN and PNN) and the proposed deep learning (CNN) methods were provided based on five measurements (SE, SP, PR, AC and MCC). Taking AC as an example, it spanned from 89.0% to 98.5%, from 89.1% to 97.3%, from 84.5% to 95.1%, and from 86.7% to 96.2% for CNN, SVM, KNN and PNN, respectively. Moreover, for MCC, it ranged from 0.72 to 0.91, from 0.72 to 0.87, from 0.65 to 0.81, and from 0.62 to 0.81, respectively. As shown, the exact AC and MCC values of CNN and SVM were slightly higher than that of the remaining methods (KNN and PNN), but no significant difference was observed for AC values (the *P*-values for AC values between any two methods were larger than 0.05). For MCC values, CNN is better than KNN and PNN with the *P*-values of 0.004 and 0.011, respectively, SVM is better than KNN and PNN with the *P*-values of 0.012 and 0.038, respectively, and there is no significant difference between CNN and SVM.

The results above indicated that, for the data sets with the highest similarity, the studied methods showed a similar performance as each other. In other words, the models trained using the high representative data sets by difference methods performed consistently well, which denoted that the training and testing data sets with the highest similarity might have a low resolution on distinguishing the performances of different methods. Therefore, in order to provide an in-depth assessment on studied methods, the training and testing data sets with the lowest similarity could be considered as more effective in providing the performance assessment of higher resolution. Moreover, in the real world of protein function annotation, it was almost impossible to have all query proteins (with function unknown) fully represented by the proteins with annotated functions. Therefore, the assessment based on the data sets with the highest similarity could only draw the upper ceiling of the methods' performances, and the data sets in most real-world occasions were much less representative. Especially for the novel or newly discovered proteins, which attract great and broad attentions, the training data set or database could not provide any representativeness to the novel ones. Therefore, compared with the upper ceiling, a bottom line (the training and testing data sets with the lowest similarity) was expected to be capable of revealing the lower limits of the performances of all studied methods.

Methods' performances based on the training and testing data sets with the lowest similarity {#sec9}
--------------------------------------------------------------------------------------------

The performances of the studied methods were calculated and assessed based on the constructed data sets with the lowest similarity (the way to construct such data sets was provided in the second section of Materials and Methods). As illustrated in [Table 3](#TB3){ref-type="table"}, the performances of three *de novo* and one deep learning methods on all 20 GO families were provided based on five measurements. Moreover, the statistical differences of these measurements between any two methods were shown in [Figure 2](#f2){ref-type="fig"}. As one of the most comprehensive parameters in any category of predictors \[[@ref57]\], the MCC reflected the stability of protein function predictor, which described the correlation between a predictive value and the actual value \[[@ref62], [@ref105], [@ref106]\]. As illustrated on the left panel of [Figure 2A](#f2){ref-type="fig"}, the variations of MCC values among methods were provided (the actual MCC value of each method was subtracted by the minimum MCC value among four different methods). As shown, the CNN method showed the consistently higher MCC values compared with the other three methods, and the MCC values of KNN method were the lowest in most of the GO families. As all GO families were ordered by their total numbers of proteins, there was no clear trend on the MCC values with the increase of protein amount. Moreover, to assess the statistical differences of MCC values between any two methods, the violin box plots based on the MCC values in [Table 3](#TB3){ref-type="table"} were drawn on the right panel of [Figure 2A](#f2){ref-type="fig"}. As illustrated, there were significant differences (*P* \< 0.01) between the MCCs of CNN and that of the rest methods, and there was no significant difference in MCCs between any two of those three *de novo* methods. These results demonstrated an enhanced stability of the CNN-based protein function annotation model compared with three popular *de novo* methods.

As another important parameter for protein function annotation assessment, the AC referred to the total number of true members (positive plus negative) divided by the number of studied proteins \[[@ref57]\], which was essential to be compared among different methods. Herein, the variations of AC values among methods (the actual AC of each method was subtracted by the minimum ACs among four different methods) were therefore calculated and provided on the left panel of [Figure 2B](#f2){ref-type="fig"}. Similar to MCCs, the CNN method showed the consistently higher AC values compared with other three methods, and the AC values of KNN method were also the lowest in most of those GO families (there was no clear trend on the AC values with the increase of protein amount either). Furthermore, to assess the statistical differences of the ACs between any two methods, the violin box plot based on the ACs in [Table 3](#TB3){ref-type="table"} was drawn on the right panel of [Figure 2B](#f2){ref-type="fig"}. As illustrated, there were significant differences (*P* \< 0.05) between the AC values of CNN and that of the rest methods, and there was no significant difference in ACs between any two of those three *de novo* methods. These results showed the elevated AC of the CNN-based protein function annotation model compared with three popular *de novo* methods.

Besides the stability (MCC) and AC, SE and SP were also frequently used to assess the methods' prediction performances on positive and negative data sets, respectively. Thus, in this study, similar analyses were also conducted and shown in [Figure 2C, D](#f2){ref-type="fig"}. Since the SP was known as an effective metric reflecting the false discovery rate, both CNN and SVM showed enhanced control on the false discovery when comparing with KNN and PNN. All in all, based on the comprehensive assessment from four different perspectives (MCC, AC, SE and SP), the CNN method proposed here was found to perform better in both prediction stability and annotation AC compared with three popular *de novo* methods. Although both CNN and SVM were found with enhanced control of false discovery rate, the SEs of CNN were found to be significantly enhanced (*P* = 0.007) compared with that of SVM.

![The EFs of different protein function annotation methods of the training and testing data sets (for all studied GO families) with the lowest similarity. On the right side, the statistical differences of the EFs between any two methods were provided as the violin box plots. ^\*^ indicated great difference of *P* \< 0.05, and ^\*\*^ denoted significant difference of *P* \< 0.01. Detailed *P*-values are provided in the [Supplementary Table S2](#sup1){ref-type="supplementary-material"}.](bbz081f3){#f3}

###### 

The total numbers of proteins and the EFs of three *de novo* (SVM, KNN and PNN) identified by two similarity-based (BLAST and HMMER) and the deep learning (CNN) methods proposed in this study based on the training and testing data sets (for all 20 studied GO families) of the lowest similarity. Each GO family was indicated by its GO ID, and its corresponding GO term was provided in [Table 1](#TB1){ref-type="table"}

  GO ID        No. of proteins identified by each method   EF                                                                          
  ------------ ------------------------------------------- ------ -------- ------ ------ ------ ------- ------- ------ ------- ------- -------
  GO:0009975   56                                          235    657      1416   1594   1347   53.61   0       2.28   3.18    8.48    11.14
  GO:0097472   202                                         434    619      561    1598   923    44.59   14.65   8.56   13.22   8.29    14.92
  GO:0004721   352                                         712    1824     1402   2403   1844   32.73   12.36   5.17   7.17    6.28    8.41
  GO:0003712   637                                         1403   2648     3114   4408   3541   10.79   3.38    2.19   2.40    2.80    3.65
  GO:0051347   725                                         1689   3873     1421   5858   4521   9.15    3.37    1.22   4.17    2.43    3.22
  GO:0043086   1087                                        2291   3822     528    5911   4888   7.75    2.63    1.92   9.37    2.14    2.67
  GO:0016746   924                                         2173   3878     401    2076   1604   12.61   3.51    2.51   17.44   7.76    10.44
  GO:0019787   1954                                        2339   3822     3921   3328   2499   7.72    4.79    2.67   3.06    5.02    6.62
  GO:0016757   881                                         1265   4146     2352   1770   1451   11.20   6.05    2.56   3.88    8.36    10.20
  GO:0003735   520                                         750    965      1564   1207   1029   33.03   21.22   17.8   10.98   14.58   17.10
  GO:0051336   1436                                        4334   6885     6693   7187   5887   3.76    1.10    0.81   1.26    1.81    2.28
  GO:0043085   2152                                        4710   8846     8082   7984   6470   4.27    1.78    1.23   1.53    1.83    2.29
  GO:0044093   3458                                        5172   9417     2664   8654   7048   2.65    1.61    1.10   2.79    1.69    2.07
  GO:0008233   2850                                        3842   8106     5906   5409   4327   3.52    1.85    1.18   1.50    2.24    2.77
  GO:0003700   3877                                        6586   6861     6604   6537   5167   4.07    1.87    1.66   1.84    2.58    3.27
  GO:0016788   3975                                        4867   9351     7019   5338   4414   2.45    1.75    1.18   1.52    2.72    3.33
  GO:0004672   2904                                        5918   8287     4895   6621   4633   3.87    1.40    1.35   2.05    2.21    2.96
  GO:0016817   2207                                        5443   10 649   8903   6531   5053   5.15    1.89    1.24   1.48    2.43    3.13
  GO:0038023   4230                                        5919   7314     6684   5616   3573   3.06    1.93    1.79   2.03    2.60    3.48
  GO:1902494   4133                                        6900   10 017   8399   6466   4991   2.45    1.31    1.04   1.35    2.16    2.84

In-depth assessment on the false discovery rates based on genome scanning {#sec10}
-------------------------------------------------------------------------

Besides the SP, the EF was one of the most popular and effective metrics for assessing the false discovery rate of any functional annotation method \[[@ref57]\]. As known, the SP values assess the false discovery rate via only considering the prediction performance on the PND, while the EF evaluates the false discovery by fully considering the real-world true members of a particular GO family. Therefore, the EFs were applied in this study to complement the SP and further make in-depth assessment on the false discovery rate of each studied methods. In other words, in order to evaluate the false discovery rate of each method in the real world, multiple methods (CNN, BLAST, HMMER, SVM, KNN and PNN) were used to scan the human genome to identify human proteins belonging to each GO family. As shown in [Table 4](#TB4){ref-type="table"}, the total numbers of proteins identified by different methods together with their corresponding EFs were provided. Moreover, the EFs of each method based on different GO families were illustrated in [Figure 3](#f3){ref-type="fig"}. As shown, there were clear variations among the EFs of different methods. Particularly, as shown on the right panel of [Figure 3](#f3){ref-type="fig"}, there were significant differences (*P* \< 0.01) between the EFs of CNN and that of all *de novo* methods and BLAST. Based on the statistical analysis conducted in this study, there was no significant variation between the EFs of CNN and that of PHMM (a probabilistic model called Poisson Hidden Markov Model, which used in the HMMER), but the calculated *P*-value (0.054) was very close to 0.05. Furthermore, as provided in [Table 4](#TB4){ref-type="table"}, the majority (17 out of 20, 85.0%) of the EFs of CNN were higher than that of PHMM. In conclusion, based on the information provided in [Figure 3](#f3){ref-type="fig"} and [Table 4](#TB4){ref-type="table"}, the deep learning strategy CNN proposed in this study showed an improved ability to control the false discovery rate.

Conclusions {#sec11}
===========

Based on the comprehensive assessment using different measurements (MCC, AC, SE and SP), the CNN method together with the protein encoding strategy proposed in this study was found to perform better in both prediction stability and annotation AC compared with the popular *de novo* methods. Moreover, the in-depth assessment revealed that it possessed an improved capacity of controlling the false discovery rate in current protein functional annotation compared with other traditional methods. All in all, this study not only provided a comprehensive analysis on the performances of the newly proposed strategy but also provided a valuable tool for the researcher in the fields of protein function annotation.

Key Points {#sec13}
----------

Functional annotation of protein sequence with high accuracy has become one of the most important issues in modern biomedical studies.A protein encoding strategy, together with a deep learning algorithm, was proposed to control false discovery rate in protein function annotation.The proposed strategy and algorithm were found to perform better in prediction stability, annotation accuracy and false discovery rate compared with the traditional methods.
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